Zimmer Biomet Holdings, Inc. ZBH
- Market cap
- $17.1B
- P/E
- 22.0×
Follow ZBH
Zimmer Biomet Holdings, Inc. (ZBH) Return on invested capital
Zimmer Biomet Holdings, Inc.'s return on invested capital over the twelve months to 30 June 2026 was 3.82%, up 0.3 percentage points from fiscal 2025 (3.50%). Over the past ten years it has ranged from 0.11% (fiscal 2018) to 4.48% (fiscal 2023); the current reading is higher than 73% of that period. That is above the Medical Devices industry median of −10.3% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Annual
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 3.50% | (0.93) |
| FY2024 | 4.43% | (0.05) |
| FY2023 | 4.48% | 1.97 |
| FY2022 | 2.51% | (0.27) |
| FY2021 | 2.78% | 2.51 |
| FY2020 | 0.27% | (3.29) |
| FY2019 | 3.56% | 3.45 |
| FY2018 | 0.11% | (2.23) |
| FY2017 | 2.34% | (0.19) |
| FY2016 | 2.53% | 1.05 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| PEN Penumbra, Inc. compare | 13.1% |
| GMED Globus Medical, Inc. compare | 9.58% |
| GEHC GE HealthCare Technologies Inc. compare | 8.37% |
| STE STERIS plc compare | 8.27% |
| PHG Koninklijke Philips N.V. compare | 6.69% |
| ZBH Zimmer Biomet Holdings, Inc. | 3.82% |
| BIO Bio-Rad Laboratories, Inc. compare | 0.49% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 0.49% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| Medical Devices industry median | −10.3% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on ZBH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement